We provide you with 20 years of free, institutional-grade data for NEOG stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NEOG. Explore the full financial landscape of NEOG stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$74,418
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Rocklin Amy M | Sale | -3,005 | $5.43 | $16,317 | 2025-08-20 |
Rocklin Amy M | Derivatives Exercise | 10,324 | 2025-08-20 | ||
Moylan John Patrick | Sale | -593 | $5.43 | $3,220 | 2025-08-20 |
Moylan John Patrick | Derivatives Exercise | 1,985 | 2025-08-20 | ||
Jones Douglas Edward | Sale | -4,160 | $5.43 | $22,589 | 2025-08-20 |
Jones Douglas Edward | Derivatives Exercise | 14,294 | 2025-08-20 | ||
ADENT JOHN EDWARD | Derivatives Exercise | 35,736 | 2025-08-20 | ||
Naemura David H. | Sale | -5,947 | $5.43 | $32,292 | 2025-08-20 |
Naemura David H. | Derivatives Exercise | 14,294 | 2025-08-20 | ||
Naemura David H. | Grant, award...etc | 821,893 | 2025-08-19 | ||
Moylan John Patrick | Grant, award...etc | 65,752 | 2025-08-19 | ||
Rocklin Amy M | Grant, award...etc | 427,385 | 2025-08-19 | ||
Nassif Mikheal | Grant, award...etc | 2,136,921 | 2025-08-19 | ||
Moylan John Patrick | Grant, award...etc | 96,936 | 2025-06-04 | ||
Naemura David H. | Grant, award...etc | 264,447 | 2025-06-04 | ||
Wainer Andrea F | Grant, award...etc | 22,393 | 2025-06-04 | ||
Rocklin Amy M | Grant, award...etc | 218,609 | 2025-06-04 | ||
Gupta Aashima | Open Market Purchase | 16,000 | $6.25 | 2025-05-12 | |
Moylan John Patrick | Sale | -1,603 | $5.15 | $8,255 | 2025-05-02 |
Moylan John Patrick | Derivatives Exercise | 4,558 | 2025-05-02 | ||
Jones Douglas Edward | Sale | -291 | $5.16 | $1,502 | 2025-04-29 |
Jones Douglas Edward | Derivatives Exercise | 845 | 2025-04-29 | ||
Rocklin Amy M | Derivatives Exercise | 564 | 2025-04-29 | ||
ADENT JOHN EDWARD | Derivatives Exercise | 2,112 | 2025-04-29 | ||
BOREL JAMES C | Open Market Purchase | 30,000 | $4.99 | 2025-04-25 | |
Woteki Catherine E | Open Market Purchase | 5,770 | $5.17 | 2025-04-25 | |
BOREL JAMES C | Open Market Purchase | 35,000 | $4.89 | 2025-04-24 | |
BOEHM WILLIAM T | Open Market Purchase | 5,000 | $5.24 | 2025-04-24 | |
Rocklin Amy M | Open Market Purchase | 12,500 | $4.99 | 2025-04-23 | |
RODRIGUEZ RAFAEL A | Open Market Purchase | 7,474 | $4.59 | 2025-04-22 | |
CAPELLO JEFFREY D | Open Market Purchase | 20,712 | $4.84 | 2025-04-22 | |
Tobin James P | Open Market Purchase | 10,000 | $4.73 | 2025-04-22 | |
Moylan John Patrick | Open Market Purchase | 10,000 | $5.07 | 2025-04-10 | |
Naemura David H. | Grant, award...etc | 55,184 | 2025-01-21 | ||
ADENT JOHN EDWARD | Open Market Purchase | 23,035 | $11.03 | 2025-01-16 | |
Naemura David H. | Open Market Purchase | 14,800 | $11.11 | 2025-01-16 | |
Naemura David H. | Sale | -5,371 | $14.14 | $75,946 | 2024-12-02 |
Naemura David H. | Derivatives Exercise | 12,911 | 2024-12-02 | ||
Bernard Thierry | Grant, award...etc | 17,207 | 2024-11-05 | ||
BOREL JAMES C | Derivatives Exercise | 1,776 | 2024-10-29 | ||
CAPELLO JEFFREY D | Derivatives Exercise | 1,776 | 2024-10-29 | ||
Gupta Aashima | Derivatives Exercise | 1,776 | 2024-10-29 | ||
BOEHM WILLIAM T | Derivatives Exercise | 1,776 | 2024-10-29 | ||
ADENT JOHN EDWARD | Sale | -11,280 | $13.81 | $155,777 | 2024-10-29 |
ADENT JOHN EDWARD | Derivatives Exercise | 38,760 | 2024-10-29 | ||
Naemura David H. | Sale | -6,450 | $13.81 | $89,075 | 2024-10-29 |
Naemura David H. | Derivatives Exercise | 15,504 | 2024-10-29 | ||
Rocklin Amy M | Sale | -2,758 | $13.81 | $38,088 | 2024-10-29 |
Rocklin Amy M | Derivatives Exercise | 9,475 | 2024-10-29 | ||
Jones Douglas Edward | Sale | -4,512 | $13.81 | $62,311 | 2024-10-29 |
Jones Douglas Edward | Derivatives Exercise | 15,504 | 2024-10-29 | ||
Tobin James P | Derivatives Exercise | 1,776 | 2024-10-29 | ||
Green Ronald D | Derivatives Exercise | 1,776 | 2024-10-29 | ||
RODRIGUEZ RAFAEL A | Derivatives Exercise | 1,776 | 2024-10-29 | ||
Woteki Catherine E | Derivatives Exercise | 1,776 | 2024-10-29 | ||
BOEHM WILLIAM T | Grant, award...etc | 18,653 | 2024-10-28 | ||
Woteki Catherine E | Grant, award...etc | 18,653 | 2024-10-28 | ||
RODRIGUEZ RAFAEL A | Grant, award...etc | 18,653 | 2024-10-28 | ||
Tobin James P | Grant, award...etc | 18,653 | 2024-10-28 | ||
Gupta Aashima | Grant, award...etc | 18,653 | 2024-10-28 | ||
Green Ronald D | Grant, award...etc | 18,653 | 2024-10-28 | ||
BOREL JAMES C | Grant, award...etc | 18,653 | 2024-10-28 | ||
CAPELLO JEFFREY D | Grant, award...etc | 18,653 | 2024-10-28 | ||
ADENT JOHN EDWARD | Open Market Purchase | 14,500 | $13.8 | 2024-10-15 | |
Jones Douglas Edward | Sale | -229 | $14.43 | $3,304 | 2024-10-15 |
Jones Douglas Edward | Derivatives Exercise | 784 | 2024-10-15 | ||
ADENT JOHN EDWARD | Sale | -892 | $14.43 | $12,872 | 2024-10-15 |
ADENT JOHN EDWARD | Derivatives Exercise | 3,064 | 2024-10-15 | ||
Rocklin Amy M | Sale | -86 | $14.43 | $1,241 | 2024-10-15 |
Rocklin Amy M | Derivatives Exercise | 294 | 2024-10-15 | ||
Jones Douglas Edward | Sale | -3,766 | $15.07 | $56,754 | 2024-10-09 |
Jones Douglas Edward | Derivatives Exercise | 12,939 | 2024-10-09 | ||
ADENT JOHN EDWARD | Sale | -9,586 | $15.07 | $144,461 | 2024-10-09 |
ADENT JOHN EDWARD | Derivatives Exercise | 32,937 | 2024-10-09 | ||
Gupta Aashima | Derivatives Exercise | 2,070 | 2024-10-09 | ||
CAPELLO JEFFREY D | Derivatives Exercise | 2,070 | 2024-10-09 | ||
Woteki Catherine E | Derivatives Exercise | 2,306 | 2024-10-09 | ||
Tobin James P | Derivatives Exercise | 2,306 | 2024-10-09 | ||
RODRIGUEZ RAFAEL A | Derivatives Exercise | 2,306 | 2024-10-09 | ||
Green Ronald D | Derivatives Exercise | 2,306 | 2024-10-09 | ||
BOREL JAMES C | Derivatives Exercise | 2,306 | 2024-10-09 | ||
BOEHM WILLIAM T | Derivatives Exercise | 2,306 | 2024-10-09 | ||
Rocklin Amy M | Sale | -2,630 | $15.07 | $39,634 | 2024-10-09 |
Rocklin Amy M | Derivatives Exercise | 9,036 | 2024-10-09 | ||
Green Ronald D | Sale | -4,019 | $17.12 | $68,805 | 2024-09-03 |
Green Ronald D | Derivatives Exercise | 0 | 2024-09-03 | ||
BOEHM WILLIAM T | Sale | -7,377 | $16.78 | $123,786 | 2024-08-26 |
BOEHM WILLIAM T | Derivatives Exercise | 0 | 2024-08-26 | ||
Moylan John Patrick | Grant, award...etc | 18,682 | 2024-08-19 | ||
Rocklin Amy M | Grant, award...etc | 176,689 | 2024-08-19 | ||
Jones Douglas Edward | Grant, award...etc | 244,647 | 2024-08-19 | ||
ADENT JOHN EDWARD | Grant, award...etc | 891,843 | 2024-08-19 | ||
Naemura David H. | Grant, award...etc | 244,647 | 2024-08-19 | ||
Tobin James P | Open Market Purchase | 3,000 | $16.86 | 2024-08-07 | |
Moylan John Patrick | Grant, award...etc | 34,516 | 2024-05-03 | ||
Jones Douglas Edward | Sale | -291 | $11.96 | $3,480 | 2024-04-26 |
Jones Douglas Edward | Derivatives Exercise | 845 | 2024-04-26 | ||
ADENT JOHN EDWARD | Sale | -615 | $11.96 | $7,355 | 2024-04-26 |
ADENT JOHN EDWARD | Derivatives Exercise | 2,113 | 2024-04-26 | ||
Jones Douglas Edward | Open Market Purchase | 10,000 | $12.36 | 2024-04-17 | |
BOREL JAMES C | Open Market Purchase | 7,500 | $13.06 | 2024-04-11 | |
ADENT JOHN EDWARD | Open Market Purchase | 23,000 | $12.36 | 2024-04-10 | |
Naemura David H. | Open Market Purchase | 12,500 | $12.51 | 2024-04-10 | |
Naemura David H. | Grant, award...etc | 559,297 | 2024-02-09 | ||
BOEHM WILLIAM T | Open Market Purchase | 2,000 | $16.05 | 2023-11-03 | |
RODRIGUEZ RAFAEL A | Derivatives Exercise | 13,716 | 2023-10-31 | ||
Gupta Aashima | Derivatives Exercise | 13,716 | 2023-10-31 | ||
Green Ronald D | Derivatives Exercise | 13,716 | 2023-10-31 | ||
CAPELLO JEFFREY D | Derivatives Exercise | 13,716 | 2023-10-31 | ||
BOREL JAMES C | Derivatives Exercise | 13,716 | 2023-10-31 | ||
Lilly Jason Warren | Derivatives Exercise | 25,004 | 2023-10-31 | ||
BOEHM WILLIAM T | Derivatives Exercise | 13,716 | 2023-10-31 | ||
Rocklin Amy M | Derivatives Exercise | 109,725 | 2023-10-31 | ||
Jones Douglas Edward | Derivatives Exercise | 179,550 | 2023-10-31 | ||
Naemura David H. | Derivatives Exercise | 179,550 | 2023-10-31 | ||
ADENT JOHN EDWARD | Derivatives Exercise | 698,251 | 2023-10-31 | ||
Woteki Catherine E | Derivatives Exercise | 13,716 | 2023-10-31 | ||
Tobin James P | Derivatives Exercise | 13,716 | 2023-10-31 | ||
Jones Douglas Edward | Open Market Purchase | 10,000 | $15.17 | 2023-10-26 | |
Lilly Jason Warren | Sale | -351 | $15.1 | $5,300 | 2023-10-17 |
Tobin James P | Open Market Purchase | 3,000 | $15.19 | 2023-10-12 | |
BOEHM WILLIAM T | Sale | -2,591 | $15.61 | $40,456 | 2023-10-12 |
Lilly Jason Warren | Sale | -1,917 | $15.69 | $30,087 | 2023-10-12 |
Naemura David H. | Open Market Purchase | 10,000 | $15.03 | 2023-10-11 | |
BOEHM WILLIAM T | Sale | -1,500 | $22.59 | $33,891 | 2023-08-22 |
BOEHM WILLIAM T | Derivatives Exercise | 0 | 2023-08-22 | ||
Hagedorn Jerome L | Sale | -194 | $16.67 | $3,234 | 2023-04-27 |
Lilly Jason Warren | Sale | -388 | $16.67 | $6,468 | 2023-04-27 |
Jones Douglas Edward | Sale | -297 | $16.67 | $4,951 | 2023-04-27 |
ADENT JOHN EDWARD | Sale | -656 | $16.67 | $10,936 | 2023-04-27 |
BOEHM WILLIAM T | Derivatives Exercise | -750 | 2023-01-30 | ||
Jones Douglas Edward | Open Market Purchase | 2,500 | $17.91 | 2023-01-18 |
The information provided in this report about NEOG stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Neogen Corporation(NASDAQ:NEOG)Â


Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous...
Website: http://www.neogen.com
Founded: 1982
Full Time Employees: 1,764
Sector: Healthcare
Industry: Diagnostics & Research